State of Wyoming’s Crinetics Pharmaceuticals CRNX Stock Holding History

State of Wyoming’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$362K	Buy	+9,676	New	+$360K	0.04%	613
2026 Q1	–	Sell	-669	Closed	-$31.1K	–	1843
2025 Q4	$31.1K	Sell	669 -307	-31%	-$13.7K	﹤0.01%	1636
2025 Q3	$40.6K	Buy	976 +225	+30%	+$7.19K	﹤0.01%	1620
2025 Q2	$21.6K	Sell	751 -319	-30%	-$9.85K	﹤0.01%	1703
2025 Q1	$35.9K	Buy	1,070 +85	+9%	+$3.17K	﹤0.01%	1536
2024 Q4	$50.4K	Buy	+985	New	+$55.1K	0.01%	1426
2022 Q3	–	Sell	-70	Closed	-$1K	–	1601
2022 Q2	$1K	Buy	70 +17	+32%	+$339	﹤0.01%	1804
2022 Q1	$1K	Buy	53 +3	+6%	+$61	﹤0.01%	1732
2021 Q4	$1K	Sell	50 -2	-4%	-$49	﹤0.01%	1801
2021 Q3	$1K	Hold	52	–	–	﹤0.01%	1173
2021 Q2	$1K	Buy	+52	New	+$914	﹤0.01%	1128

Other funds holding CRNX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jupiter Topco New York $245B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State of Wyoming's CRNX Position: Q2 2026 in Review

State of Wyoming opened a new position in Crinetics Pharmaceuticals (CRNX) in Q2 2026: 9,676 shares worth $362K. The stake represents 0.04% of the portfolio and ranks #613 among its holdings. This is a return to the name: State of Wyoming previously reported a position in CRNX as recently as Q4 2025.

State of Wyoming first reported a position in CRNX in Q2 2021 and has held it in 11 quarters since. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

State of Wyoming held 9,676 shares of Crinetics Pharmaceuticals worth $362K as of Q2 2026.
Crinetics Pharmaceuticals was a new State of Wyoming position in Q2 2026.
Crinetics Pharmaceuticals made up 0.04% of State of Wyoming's portfolio in Q2 2026, its #613 holding.
State of Wyoming first reported a position in Crinetics Pharmaceuticals in Q2 2021 and has held it in 11 quarters since.
267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.